The role of adenosine receptors and endogenous adenosine in citalopram-induced cardiovascular toxicity
Conclusions: Citalopram may lead to QT prolongation by stimulating adenosine A 1 receptors without affecting the release of adenosine.
Source: Indian Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Kubilay OransayNil HocaogluMujgan BuyukdeligozYesim TuncokSule Kalkan Source Type: research
More News: Cardiology | Cardiovascular | Celexa | Citalopram | Drugs & Pharmacology | Heart | Toxicology